Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · C27 in 2022 · Part C · HD5 Health Plan Customer Service

Reviewing Appeals Decisions

AppealsHealth PlanSource: Independent Review Entity

What it measures
This rating shows how often an independent reviewer found the health plan’s decision to deny coverage to be reasonable. (This description has been updated to better explain the measure. There have been no changes to the measure.)
How it's calculated
Percent of appeals where a plan‘s decision was “upheld” by the Independent Review Entity (IRE) (numerator) out of all the plan‘s appeals (upheld, overturned, and partially overturned appeals only) that the IRE reviewed (denominator). This is calculated as: ([Appeals Upheld] / ([Appeals Upheld] + [Appeals Overturned] + [Appeals Partially Overturned]))* 100.
Data source
Independent Review Entity (IRE) Data were obtained from the Independent Review Entity (IRE) contracted by CMS for Part C appeals. The appeals used in this measure are based on the date in the calendar year the appeal was received by the IRE, not the date a decision was reached by the IRE. If a Reopening occurs and is decided prior to June 30, 2021, the Reopened decision is used in place of the Reconsideration decision. Reopenings decided on or after June 30, 2021 are not reflected in these data the original decision result is used. The results of appeals that occur beyond Level 2 (i.e., Administrative Law Judge or Medicare Appeals Council appeals) are not included in the data.
Measurement period
01/01/2020 – 12/31/2020
Better when
Higher
Weight
2 (Measures Capturing Access)
Star assignment
Clustering
Case-mix adjusted
No
In improvement measure
Yes
Used in CAI
No
Exclusions
ShowIf the minimum number of appeals (upheld + overturned + partially overturned) is ≤ 10, the result is “Not enough data available.” Dismissed and Withdrawn appeals are excluded from this measure.
Notes
This measure includes all Standard Coverage, Standard Claim, and Expedited appeals received by the IRE, regardless of the appellant. This includes appeals requested by a beneficiary, appeals requested by a party on behalf of a beneficiary, and appeals requested by non-contract providers.
Disaster policy
Higher measure star (2021-2022) for contracts with 25% or more enrolled affected by 2020 disasters.

From the 2022 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA8893+5
3★MA9699+3
4★MA98100+2
5★MA100101+1

2022 star distribution

Not rated: Not enough data available (363); Plan not required to report measure (63); No data available (39)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA< 88 %>= 88 % to < 96 %>= 96 % to < 98 %>= 98 % to < 100 %100%
2026MA< 83 %>= 83 % to < 96 %>= 96 % to < 98 %>= 98 % to < 100 %100%
2025MA< 78 %>= 78 % to < 92 %>= 92 % to < 96 %>= 96 % to < 99 %>= 99 %
2024MA< 73 %>= 73 % to < 88 %>= 88 % to < 96 %>= 96 % to < 100 %100%
2023MA< 68 %>= 68 % to < 83 %>= 83 % to < 91 %>= 91 % to < 97 %>= 97 %
2022MA< 69 %>= 69 % to < 84 %>= 84 % to < 91 %>= 91 % to < 96 %>= 96 %
2021MANA>= 43 % to < 69 %>= 69 % to < 85 %>= 85 % to < 94 %>= 94 %
2020MA< 74%? 74% to < 81%? 81% to < 90%? 90% to < 95%? 95%
2019MA< 59%? 59% to < 78%? 78% to < 88%? 88% to < 97%? 97%
2018MA< 62%? 62% to < 76%? 76% to < 86%? 86% to < 93%? 93%
2017MA< 71%? 71% to < 77%? 77% to < 88%? 88% to < 93%? 93%
2016MA< 73%? 73% to < 85%? 85% to < 89%? 89% to < 94%? 94%
2015MA< 67%? 67% to < 77%? 77% to < 87%? 87% to < 95%? 95%

Lowest-scoring contracts, 2022

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H5989 Healthfirst Medicare PlanHealthfirst, Inc.12,7564320480%
H9082 Molina Healthcare of New Mexico, Inc.Molina Healthcare, Inc.,—7030210%
H8010 Clover HealthClover Health Holdings, Inc.3,862722—191%
H3251 Blue Cross and Blue Shield of New MexicoHealth Care Service Corporation19,8807330181%
H8634 Blue Cross and Blue Shield of IL, NM, OK, TXHealth Care Service Corporation27,1347430171%
H3890 Johns Hopkins Advantage MDJohns Hopkins Healthcare LLC6,7877530161%
H0107 Blue Cross and Blue Shield of MontanaHealth Care Service Corporation102,2077630152%
H2563 Sentara MedicareSentara Health Care (SHC)875772—142%
H2168 VillageCareMAXVillage Care of New York, Inc.10,8887730142%
H5496 Imperial Health Plan of California, Inc.Imperial Health Plan of California54,253782—132%
H2171 Care N' Care Insurance CompanyTexas Health Resources—7830132%
H3293 MMM of Florida, Inc.Summit Master Company, LLC—792—123%
H1610 Aetna MedicareCVS Health Corporation10,9098030113%
H8130 Molina Healthcare of FloridaMolina Healthcare, Inc.,—802—113%
H5945 Prominence Health PlanUniversal Health Services, Inc.23,7208030113%
H4140 Doctors HealthCare Plans, Inc.DOCTORS HEALTHCARE PLANS, INC.27,878802—113%
H8379 Priority Health MedicareCorewell Health8,471812—104%
H3811 Samaritan Advantage Health PlansSamaritan Health Services, Inc.1,371823094%
H2032 Baylor Scott & White Health PlanBaylor Scott & White Health9,246823094%
H5215 Network Health Medicare Advantage PlansNetwork Health, Inc.132,580833085%
H3471 Health Alliance NorthwestThe Carle Foundation—843075%
H1666 Blue Cross and Blue Shield of NM, TXHealth Care Service Corporation15,741843075%
H6988 Anthem Blue Cross and Blue Shield HPElevance Health, Inc.10,164843075%
H1463 Health Alliance MedicareThe Carle Foundation—853066%
H5211 Security Health Plan of Wisconsin, Inc.Sanford Health79,289854066%

History

Star yearCodeNameMeasuredWeightSource
2027C31Reviewing Appeals Decisions01/01/2025 – 12/31/20252Independent Review Entity
2026C32Reviewing Appeals Decisions01/01/2024 – 12/31/20242Independent Review Entity
2025C29Reviewing Appeals Decisions01/01/2023 – 12/31/20234Independent Review Entity
2024C29Reviewing Appeals Decisions01/01/2022 – 12/31/20224Independent Review Entity
2023C27Reviewing Appeals Decisions01/01/2021 – 12/31/20214Independent Review Entity
2022C27Reviewing Appeals Decisions01/01/2020 – 12/31/20202Independent Review Entity
2021C31Reviewing Appeals Decisions01/01/2019 – 12/31/20192Independent Review Entity
2020C32Reviewing Appeals Decisions01/01/2018– 12/31/20181.5Independent Review Entity
2019C33Reviewing Appeals Decisions01/01/2017 – 12/31/20171.5Independent Review Entity
2018C33Reviewing Appeals Decisions01/01/2016 – 12/31/20161.5Independent Review Entity
2017C31Reviewing Appeals Decisions01/01/2015 - 12/31/20151.5Independent Review Entity
2016C31Reviewing Appeals Decisions01/01/2014 - 12/31/20141.5Independent Review Entity
2015C33Reviewing Appeals Decisions01/01/2013 - 12/31/20131.5Independent Review Entity